Identification of a novel splicing-altering LAMP2 variant in a Chinese family with Danon disease

ESC Heart Fail. 2023 Aug;10(4):2479-2486. doi: 10.1002/ehf2.14417. Epub 2023 Jun 5.

Abstract

Aims: This study aimed to identify a novel splicing-altering LAMP2 variant associated with Danon disease.

Methods and results: To identify the potential genetic mutation in a Chinese pedigree, whole-exome sequencing was conducted in the proband, and Sanger sequencing was performed on the proband's parents. To verify the impact of the splice-site variant, a minigene splicing assay was applied. The AlphaFold2 analysis was used to analyse the mutant protein structure. A splice-site variant (NM_013995.2:c.864+5G>A) located at intron 6 of the LAMP2 gene was identified as a potential pathogenic variant. The minigene splicing revealed that this variant causes exon 6 to be skipped, resulting in a truncated protein. The AlphaFold2 analysis showed that the mutation caused a protein twist direction change, leading to conformational abnormality.

Conclusions: A novel splice-site variant (NM_013995.2:c.864+5G>A) located at intron 6 of the LAMP2 gene was identified. This discovery may enlarge the LAMP2 variant spectrum, promote accurate genetic counselling, and contribute to the diagnosis of Danon disease.

Keywords: Danon disease; Genetic diagnosis; LAMP2; Minigene assay; Splicing mutation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • East Asian People
  • Glycogen Storage Disease Type IIb* / diagnosis
  • Glycogen Storage Disease Type IIb* / genetics
  • Humans
  • Lysosomal-Associated Membrane Protein 2 / genetics
  • Mutation
  • Pedigree
  • RNA Splicing*

Substances

  • LAMP2 protein, human
  • Lysosomal-Associated Membrane Protein 2